A new Phase 1 trial found that immunotherapy is effective and safe for cancer prevention. It can spare patients with oral pre-malignancies from having surgery and demonstrated an 85% clinical response rate, our Dr. Moran Amit presented at #AACR26. More about his research: https://t.co/AFI3UcBEP0 #EndCancer